MENU
KOD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kodiak Sciences (KOD) Ownership - Who owns Kodiak Sciences?
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1200 Page Mill Road
Phone
+1 650 281-0850
Employees
111
Web
https://www.kodiak.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
350.61M
P/E Ratio
N/A
Total Cash
138.85M
Projected Growth
N/A
Total Debt
67.64M
Revenue
N/A
Risk (Beta)
2.49
Dividend Yield
N/A
Total Cash/Share
2.63
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
KOD
Capitalization
351M
P/E Ratio
N/A
Risk (Beta)
2.49
Dividend Yield
N/A
Total Cash
139M
Total Cash/Share
2.63
Total Debt
67.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
109M
P/B Ratio
3.22
Cash Flow
N/A
Earnings
-3.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
4.62
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-162.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-52.04
Shares Held By Institutions
150M
Shares Outstanding - Current
52.8M
Total Liabilities
189M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-33.166
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel therapies for the treatment of retinal disease
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1200 Page Mill Road
Phone
+1 650 281-0850
Employees
111
Web
https://www.kodiak.com